MktsMarkets

Atea Pharmaceuticals, Inc.
NASDAQ: AVIRKey statistics
AVIR News
Stories mentioning AVIR from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 41,134 | 47,818 | 38,347 | 32,275 | 29,584 | 25,671 | 26,159 | 34,696 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 48,008 | 54,934 | 45,567 | 41,345 | 39,041 | 39,026 | 37,202 | 46,916 |
| Operating Income (Loss) | (48,008) | (54,934) | (45,567) | (41,345) | (39,041) | (39,026) | (37,202) | (46,916) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (45,390) | (51,635) | (41,853) | (36,954) | (34,069) | (33,318) | (30,925) | (40,279) |
| Tax Provision | 50.00 | (6,768) | 196.00 | 207.00 | 203.00 | 225.00 | 226.00 | 243.00 |
| Net Income (Loss) | (45,440) | (44,867) | (42,049) | (37,161) | (34,272) | (33,543) | (31,151) | (40,522) |
| Earnings Per Share (Basic) | (0.57) | (0.55) | (0.53) | (0.44) | (0.40) | (0.40) | (0.37) | (0.48) |
| Earnings Per Share (Diluted) | (0.57) | (0.55) | (0.53) | (0.44) | (0.40) | (0.40) | (0.37) | (0.48) |
| Weighted Average Shares Outstanding (Basic) | 79,198 | 81,495 | 79,052 | 83,747 | 85,159 | 84,265 | 84,422 | 84,254 |
| Weighted Average Shares Outstanding (Diluted) | 79,198 | 81,495 | 79,052 | 83,747 | 85,159 | 84,265 | 84,422 | 84,254 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About AVIR
Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) is a stock listed on the Nasdaq Stock Market under the ticker symbol AVIR. It last traded at $3.96 (Nov 20, 2026, 4:00 PM ET), up 0.8% on the day. That gives Atea Pharmaceuticals a market capitalisation of $315.6M.
Over the past 52 weeks AVIR has traded between $2.92 and $6.45.
For the quarter ended Mar 31, 2026 it reported a net loss of $45.4M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$45.4M |
| Dec 31, 2025 | — | -$44.9M |
| Sep 30, 2025 | — | -$42.0M |
| Jun 30, 2025 | — | -$37.2M |
From Atea Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…